CEACAM5 and neoplasm: The following risk factors for TSH drop out have been reported: a maximum tumor diameter > 40 mm, >12 chemotherapy cycles, progressive disease during first-line chemotherapy, and carcinoembryonic antigen levels >30 ng/ml [31].